Literature DB >> 23283247

Follow-up of secondary diabetic complications after pancreas transplantation.

Ugo Boggi1, Carlo Maria Rosati, Piero Marchetti.   

Abstract

PURPOSE OF REVIEW: Successful pancreas transplantation restores physiologic glycemic and metabolic control. Its effects on overall patient survival (especially for simultaneous pancreas-kidney transplantation) are clear-cut. We herein review the available literature to define the impact of pancreas transplantation on chronic complications of diabetes mellitus. RECENT
FINDINGS: With longer-term follow-up, wider patient populations, and more accurate investigational tools (clinical and functional tests, noninvasive imaging, histology, and molecular biology), growing data show that successful pancreas transplantation may slow the progression, stabilize, and even favor the regression of secondary complications of diabetes, both microvascular and macrovascular, in a relevant proportion of recipients.
SUMMARY: Patients who are referred for pancreas transplantation usually suffer from advanced chronic complications of diabetes, which have classically been deemed irreversible. A successful pancreas transplantation is often able to slow the progression, stabilize, and even reverse many microvascular and macrovascular complications of diabetes. Growing clinical evidence shows that the expected natural history of long-term diabetic complications can be significantly modified by successful pancreas transplantation.

Entities:  

Mesh:

Year:  2013        PMID: 23283247     DOI: 10.1097/MOT.0b013e32835c28c5

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  6 in total

Review 1.  Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes.

Authors:  Marina Figliuzzi; Barbara Bonandrini; Sara Silvani; Andrea Remuzzi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

2.  Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).

Authors:  Angelika C Gruessner; Rainer W G Gruessner
Journal:  Rev Diabet Stud       Date:  2016-03-14

Review 3.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

4.  Parathyroid Hormone-Related Peptide (1-36) Enhances Beta Cell Regeneration and Increases Beta Cell Mass in a Mouse Model of Partial Pancreatectomy.

Authors:  Anaïs Mozar; Hugo Lin; Katoura Williams; Connie Chin; Rosemary Li; Nagesha Guthalu Kondegowda; Andrew F Stewart; Adolfo Garcia-Ocaña; Rupangi Chhaya Vasavada
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 5.  Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?

Authors:  Vishnu Swaroop Venkatanarasimhamoorthy; Adam D Barlow
Journal:  Curr Diab Rep       Date:  2018-07-20       Impact factor: 4.810

6.  Novel surgical technique and efficacy analysis of donor pancreas preparation without vascular reconstruction in pancreas transplantation.

Authors:  Wen-Wei Liao; Xiang-Chao Ling; Cheng Zhang; Fu-Rong Liu; Xiao-Feng Zhu; Xiao-Shun He; An-Bin Hu
Journal:  J Int Med Res       Date:  2019-09-10       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.